BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,570.00
+15.00 (0.33%)
At close: Aug 3, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 460.93 billion as of August 3, 2026. Its market cap has decreased by -11.53% in one year.
Market Cap
460.93B
Enterprise Value
100.91B
Revenue
122.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,570.00
ChartMarket Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 460.93B, a decrease of -57.52%. That is a compound annual growth rate of -21.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 462.44B | -16.59% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 2.68T |
| SD Biosensor | 759.58B |
| T&L Co., Ltd. | 445.75B |
| Samyang Biopharm | 286.28B |
| Vieworks | 189.90B |
| Shinhung | 128.81B |
| Dongbang Medical | 111.37B |
| EOFLOW | 51.11B |